September 15 — World Lymphoma Awareness Day Every year on September 15, patient groups, clinicians, and researchers mark World Lymphoma Awareness Day to raise recognition…
September 15, 2026
August 14, 2026
Allogene’s ALPHA3 Data and FDA Designations Sharpen the Case for Cema-Cel in Lymphoma
Key Points Allogene Therapeutics reported Q2 2026 results and a business update, highlighted by an interim futility analysis in the pivotal ALPHA3 trial of cema-cel…
April 13, 2026
Allogene Stock Jumps As Off‑The‑Shelf CAR‑T Wipes Out Residual Lymphoma In Early Readout
Allogene Therapeutics (NASDAQ: ALLO) is up more than 50%, trading sharply higher after early data showed its off‑the‑shelf CAR‑T candidate cema‑cel eliminated lingering lymphoma cells far…